The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

A Toll-like receptor recognizes bacterial DNA

Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · see citing works

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works

Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358 · see citing works

Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276 · see citing works

Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens

Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 987 · see citing works

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699 · see citing works

Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes

Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 606 · see citing works

Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes

Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 558 · see citing works

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

Lasiç, D. D., Martin, F. J., Gabizón, A., Huang, S. K., & Papahadjopoulos, D. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90162-2 · Cited by 545 · see citing works

Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles

Senior, J. H., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90337-8 · Cited by 521 · see citing works

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

Ishida, T., & Kiwada, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 496 · see citing works

The Proteolytic Activation Systems of Complement

Reid, K. B. M., & Porter, R. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002245 · Cited by 480 · see citing works

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479 · see citing works

B‐cell activation by T‐cell‐independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms

Vos, Q., Lees, A., Wu, Z.-Q., Snapper, C. M., & Mond, J. J. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 469 · see citing works

In Vivo Targeted Delivery of Nanoparticles for Theranosis

Koo, H., Huh, M. S., Sun, I., Yuk, S. H., Choi, K., Kim, K., & Kwon, I. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000138 · Cited by 447 · see citing works

Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes

Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421 · see citing works

Controlling the Physical Behavior and Biological Performance of Liposome Formulations Through Use of Surface Grafted Poly(ethylene Glycol)

Allen, C. J., Santos, N. D., Gallagher, R., Chiu, G. N. C., Shu, Y., Li, W. M., Johnstone, S. A., Janoff, A. S., Mayer, L. D., Webb, M. S., et al. (2002) · Bioscience Reports · doi:10.1023/a:1020186505848 · Cited by 388 · see citing works

PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382 · see citing works

Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes

Ishida, T., Harada, M., Wang, X., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365 · see citing works

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350 · see citing works

Accelerated clearance of PEGylated liposomes in rats after repeated injections

Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00462-5 · Cited by 327 · see citing works

Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes upon Repeated Injection

Laverman, P., Carstens, M. G., Boerman, O. C., Dams, E. T. M., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298 · see citing works

Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection

Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.017 · Cited by 290 · see citing works

Supramolecular Nanodevices: From Design Validation to Theranostic Nanomedicine

Cabral, H., Nishiyama, N., & Kataoka, K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200094a · Cited by 290 · see citing works

Antibodies against Polyethylene Glycol Produced in Animals by Immunization with Monomethoxy Polyethylene Glycol Modified Proteins

Richter, A. W., & Akerblom, E. B. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000233309 · Cited by 282 · see citing works

Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes

Judge, A. D., McClintock, K., Phelps, J. R., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280 · see citing works

Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes

Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.001 · Cited by 270 · see citing works

Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.

Gabizón, A., Dagan, A., Goren, D., Barenholz, Y., & FUKS, Z. Y. (1982) · PubMed · Cited by 263 · see citing works

Non-viral and hybrid vectors in human gene therapy: an update

Schmidt‐Wolf, G., & Schmidt‐Wolf, I. G. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00005-4 · Cited by 253 · see citing works

Polymer-coated long-circulating microparticulate pharmaceuticals

Torchilin, V. P. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006831 · Cited by 236 · see citing works

The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens

Zandvoort, A., & Timens, W. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01953.x · Cited by 225 · see citing works

Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid

Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211 · see citing works

Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression

Ambegia, E., Ansell, S. M., Cullis, P. R., Heyes, J. A., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 203 · see citing works

Recent advances in liposomal drug-delivery systems

Chonn, A., & Cullis, P. R. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80115-4 · Cited by 200 · see citing works

Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

Ishihara, T., Takeda, M., Sakamoto, H., Kimoto, A., Kobayashi, C., Takasaki, N., Yuki, K., Tanaka, K., Takenaga, M., Igarashi, R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9943-x · Cited by 196 · see citing works

Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle

Lü, W., Wan, J., She, Z., & Jiang, X. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.015 · Cited by 193 · see citing works

Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction

Szebeni, J., Baranyi, L., Sávay, S., Bodo, M., Morse, D. S., Bašta, M., Stahl, G. L., Bünger, R., & Alving, C. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1319 · Cited by 172 · see citing works

Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine

Webb, M. S., Saxon, D., Wong, F. M. P., Lim, H. J., Wang, Z., Bally, M. B., Choi, L. S. L., Cullis, P. R., & Mayer, L. D. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00077-7 · Cited by 171 · see citing works

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats

Ichihara, M., Shimizu, T., Imoto, A., Hashiguchi, Y., Uehara, Y., Ishida, T., & Kiwada, H. (2010) · Pharmaceutics · doi:10.3390/pharmaceutics3010001 · Cited by 157 · see citing works

Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers

Ishihara, T., Maeda, T., Sakamoto, H., Takasaki, N., Shigyo, M., Ishida, T., Kiwada, H., Mizushima, Y., & Mizushima, T. (2010) · Biomacromolecules · doi:10.1021/bm100754e · Cited by 155 · see citing works

Particle size-dependent triggering of accelerated blood clearance phenomenon

Koide, H., Asai, T., Hatanaka, K., Urakami, T., Ishii, T., Kenjo, E., Nishihara, M., Yokoyama, M., Ishida, T., Kiwada, H., et al. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.004 · Cited by 148 · see citing works

Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgM

Cheng, T., Wu, P.-Y., Wu, M., Chern, J., & Roffler, S. R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980143z · Cited by 147 · see citing works

T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes

Koide, H., Asai, T., Hatanaka, K., Akai, S., Ishii, T., Kenjo, E., Ishida, T., Kiwada, H., Tsukada, H., & Oku, N. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.022 · Cited by 143 · see citing works

Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon

Shiraishi, K., Hamano, M., Ma, H., Kawano, K., Maitani, Y., Aoshi, T., Ishii, K. J., & Yokoyama, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.016 · Cited by 141 · see citing works

Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs

Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127 · see citing works

Accelerated Blood Clearance of PEGylated PLGA Nanoparticles Following Repeated Injections: Effects of Polymer Dose, PEG Coating, and Encapsulated Anticancer Drug

Saadati, R., Dadashzadeh, S., Abbasian, Z., & Soleimanjahi, H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0934-y · Cited by 127 · see citing works

The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats

Ishida, T., Kashima, S., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.009 · Cited by 125 · see citing works

Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes

Xu, H., Wang, K. Q., Deng, Y. H., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.049 · Cited by 118 · see citing works

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

La-Beck, N. M., Zamboni, B. A., Gabizón, A., Schmeeda, H., Amantea, M., Gehrig, P. A., & Zamboni, W. C. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1664-2 · Cited by 118 · see citing works

Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice

Ishida, T., Ichikawa, T., Ichihara, M., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.011 · Cited by 116 · see citing works

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives

Xu, H., Deng, Y., Chen, D., HONG, W., Lu, Y., & Dong, X. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.009 · Cited by 109 · see citing works

Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA

Tagami, T., Uehara, Y., Moriyoshi, N., Ishida, T., & Kiwada, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.013 · Cited by 93 · see citing works

A Nanoparticle System Specifically Designed to Deliver Short Interfering RNA Inhibits Tumor Growth In vivo

Yagi, N., Manabe, I., Tottori, T., Ishihara, A., Ogata, F., Kim, J. H., Nishimura, S., Fujiu, K., Oishi, Y., Itaka, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3945 · Cited by 92 · see citing works

Antitumor activity of an epithelial cell adhesion molecule–targeted nanovesicular drug delivery system

Hussain, S., Plückthun, A., Allen, T. M., & Zangemeister‐Wittke, U. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0615 · Cited by 89 · see citing works

Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration

Romberg, B., Oussoren, C., Snel, C. J., Carstens, M. G., Hennink, W. E., & Storm, G. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.005 · Cited by 87 · see citing works

Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma

Miyazaki, T., Kato, H., Shitara, Y., Yoshikawa, M., Tajima, K., Masuda, N., Shouji, H., Tsukada, K., Nakajima, T., & Kuwano, H. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5 · Cited by 84 · see citing works

Twice‐weekly administration of peginterferon‐α‐2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Formann, E., Jessner, W., Bennett, L. N., et al. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00446.x · Cited by 81 · see citing works

Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production

Tagami, T., Nakamura, K., Shimizu, T., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.006 · Cited by 81 · see citing works

Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles

Deng, Y., Zhao, Wang, Yan, Y., Ma, Zang, & She (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30943 · Cited by 79 · see citing works

Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon

Chen, D., Shen, Y., Liu, Mu, M., Liang, L., Wang, & Sun (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24344 · Cited by 78 · see citing works

Induction of CD4 + T-Cell-Independent Immunoglobulin Responses by Inactivated Influenza Virus

Sha, Z., & Compans, R. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.4999-5005.2000 · Cited by 78 · see citing works

CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes

Tagami, T., Nakamura, K., Shimizu, T., Yamazaki, N., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.017 · Cited by 77 · see citing works

Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria

Joshi, M., Pathak, S., Sharma, S., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.012 · Cited by 71 · see citing works

A frustrating problem: Accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats

Zhao, Y., Wang, C., Wang, L., Yang, Q., Tang, W., She, Z., & Deng, Y. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.023 · Cited by 70 · see citing works

Efficient Clearance of Poly(ethylene glycol)-Modified Immunoenzyme with Anti-PEG Monoclonal Antibody for Prodrug Cancer Therapy

Cheng, T., Chen, B., Chern, J., Wu, M., & Roffler, S. R. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990147j · Cited by 67 · see citing works

A Double-modulation Strategy in Cancer Treatment With a Chemotherapeutic Agent and siRNA

Nakamura, K., Lila, A. S. A., Matsunaga, M., Doi, Y., Ishida, T., & Kiwada, H. (2011) · Molecular Therapy · doi:10.1038/mt.2011.174 · Cited by 66 · see citing works

Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-β inhibitor

Kumagai, M., Kano, M. R., Morishita, Y., Ota, M., Imai, Y., Nishiyama, N., Sekino, M., Ueno, S., Miyazono, K., & Kataoka, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.002 · Cited by 64 · see citing works

A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers

Liu, Y., Reidler, H., Pan, J., Milunic, D., Qin, D., Chen, D., Vallejo, R. P., & Yin, R. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.07.003 · Cited by 64 · see citing works

The complement system in liposome clearance: Can complement deposition be inhibited?

Devine, D. V., & Bradley, A. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00129-4 · Cited by 59 · see citing works

Accelerated Blood Clearance of Pegylated Liposomal Topotecan: Influence of Polyethylene Glycol Grafting Density and Animal Species

Li, C., Cao, J., Wang, Y., Zhao, X., Deng, C., Wei, N., Yang, J., & Cui, J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23254 · Cited by 57 · see citing works

Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats

Ma, Y., Yang, Q., Wang, L., Zhou, X., Zhao, Y., & Deng, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.014 · Cited by 57 · see citing works

Kanamycin A‐Derived Cationic Lipids as Vectors for Gene Transfection

Sainlos, M., Hauchecorne, M., Oudrhiri, N., et al. (2005) · ChemBioChem · doi:10.1002/cbic.200400344 · Cited by 57 · see citing works

Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy

Deng, Y., Yang, P., Ma, Zhao, She, Wang, Li, X., & Wang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41701 · Cited by 54 · see citing works

Pharmacokinetic change of nanoparticulate formulation “Lactosome” on multiple administrations

Hara, E., Makino, A., Kurihara, K., Yamamoto, F., Ozeki, E., & Kimura, S. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.07.011 · Cited by 54 · see citing works

Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's Disease

Brouwers, A. H., Jong, D. D., Dams, E. T. M., et al. (2000) · Journal of drug targeting · doi:10.3109/10611860008997901 · Cited by 54 · see citing works

Hemoglobin Vesicles, Polyethylene Glycol (PEG)ylated Liposomes Developed as a Red Blood Cell Substitute, Do Not Induce the Accelerated Blood Clearance Phenomenon in Mice

Taguchi, K., Urata, Y., Anraku, M., Watanabe, H., Kadowaki, D., Sakai, H., Horinouchi, H., Kobayashi, K., Tsuchida, E., Maruyama, T., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028852 · Cited by 51 · see citing works

Accelerated Blood Clearance Was Not Induced for a Gadolinium-Containing PEG-poly(L-lysine)-Based Polymeric Micelle in Mice

Ma, H., Shiraishi, K., Minowa, T., Kawano, K., Yokoyama, M., Hattori, Y., & Maitani, Y. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-0018-9 · Cited by 51 · see citing works

Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration

Sun, W., Zou, W., Huang, G., et al. (2008) · Journal of drug targeting · doi:10.1080/10611860801927598 · Cited by 44 · see citing works

Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan

Li, C., Zhao, X., Wang, Y., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.012 · Cited by 44 · see citing works

Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application

Lila, A. S. A., Eldin, N. E., Ichihara, M., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.030 · Cited by 39 · see citing works

Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: Promise for clinical application

Nagao, A., Lila, A. S. A., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.015 · Cited by 39 · see citing works

Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase

Cui, J., Li, C., Wang, C., Li, Y., Zhang, L., Zhang, L., & Yang, H. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.12.0011 · Cited by 39 · see citing works

The accelerated clearance on repeated injection of pegylated liposomes in rats: laboratory and histopathological study.

Ishida, T., Maeda, R., Ichihara, M., et al. (2002) · PubMed · Cited by 36 · see citing works

Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase

Cui, J., Li, C., Wang, C., et al. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp/60.12.0011 · Cited by 32 · see citing works

Repeat Injection Studies of Technetium-99M-Labeled Peg-Liposomes in the Same Animal

Coins, B., Phillips, W. T., & Klipper, R. W. (1998) · Journal of Liposome Research · doi:10.3109/08982109809035531 · Cited by 31 · see citing works

An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin

Tardi, P. G., Swartz, E. N., Harasym, T. O., et al. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00178-6 · Cited by 26 · see citing works

Effect of Repeated Intravenous Administration on the Circulation Kinetics of Poly(Ethyleneglycol)-Liposomes in Rats

Oussoren, C., & Storm, G. (1999) · Journal of Liposome Research · doi:10.3109/08982109909018655 · Cited by 25 · see citing works

Fluid Resuscitation with Hemoglobin Vesicles Prevents Escherichia coli Growth via Complement Activation in a Hemorrhagic Shock Rat Model

Taguchi, K., Ogaki, S., Watanabe, H., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177832 · Cited by 12 · see citing works

Cardiac pheochromocytoma: A new case reported

Knop, G., & Margaria, R. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.07.028 · Cited by 7 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release

Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070 · see citing works

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works

Block copolymer micelles in nanomedicine applications

Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309 · see citing works

Targeting drugs to tumours using cell membrane-coated nanoparticles

Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980 · see citing works

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757 · see citing works

Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699 · see citing works

Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696 · see citing works

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation

Hoang Thi, T. T., Pilkington, E. H., Nguyen, D. H., Lee, J. S., Park, K. D., & Truong, N. P. (2020) · Polymers · doi:10.3390/polym12020298 · Cited by 668 · see citing works

Anti‐ <scp>PEG</scp> immunity: emergence, characteristics, and unaddressed questions

Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593 · see citing works

Self-assembled mRNA vaccines

Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works

Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330 · see citing works

The blood clearance kinetics and pathway of polymeric micelles in cancer drug delivery

Sun, X., Wang, G., Zhang, H., Hu, S., Liu, X., Tang, J., & Shen, Y. (2018) · ACS Nano · doi:10.1021/acsnano.8b02830 · Cited by 253 · see citing works

The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes

Kierstead, P. H., Okochi, H., Venditto, V. J., Chuong, T. C., Kivimae, S., Fréchet, J. M. J., & Szoka, F. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.023 · Cited by 210 · see citing works

Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety

Vlatkovic, I. (2021) · Biomedicines · doi:10.3390/biomedicines9050530 · Cited by 112 · see citing works

Nanoparticle technology for treatment of Parkinson’s disease: The role of surface phenomena in reaching the brain

Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102 · see citing works

Poly(2-ethyl-2-oxazoline)-PLA-g-PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics

Gaspar, V. M., Gonçalves, C., de Melo-Diogo, D., Costa, E. C., Queiroz, J. A., Pichon, C., Sousa, F., & Correia, I. J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.040 · Cited by 91 · see citing works

Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment

de Maar, J. S., Sofias, A. M., Porta Siegel, T., Vreeken, R. J., Moonen, C., Bos, C., & Deckers, R. (2020) · Theranostics · doi:10.7150/thno.38625 · Cited by 71 · see citing works

Biotin-decorated all-HPMA polymeric micelles for paclitaxel delivery

Wang, Y., van Steenbergen, M. J., Beztsinna, N., Shi, Y., Lammers, T., van Nostrum, C. F., & Hennink, W. E. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.013 · Cited by 66 · see citing works

&lt;p&gt;Noninvasive Molecular Imaging of the Enhanced Permeability and Retention Effect by &lt;sup&gt;64&lt;/sup&gt;Cu-Liposomes: In vivo Correlations with &lt;sup&gt;68&lt;/sup&gt;Ga-RGD, Fluid Pressure, Diffusivity and &lt;sup&gt;18&lt;/sup&gt;F-FDG&lt;/p&gt;

Børresen, B., Hansen, A. E., Fliedner, F. P., Henriksen, J. R., Elema, D. R., Brandt-Larsen, M., Kristensen, L. K., Kristensen, A. T., Andresen, T. L., & Kjær, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s239172 · Cited by 28 · see citing works

LIMITATIONS OF PEGYLATED NANOCARRIERS: UNFAVOURABLE PHYSICOCHEMICAL PROPERTIES, BIODISTRIBUTION PATTERNS AND CELLULAR AND SUBCELLULAR FATES

Sebak, A. A. (2018) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2018v10i5.27568 · Cited by 39 · see citing works

PEGylated nanocarriers: A promising tool for targeted delivery to the brain

Gajbhiye, K. R., Pawar, A., Mahadik, K. R., & Gajbhiye, V. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110770 · Cited by 100 · see citing works

PASylation improves pharmacokinetic of liposomes and attenuates anti-PEG IgM production: An alternative to PEGylation

Zhang, Q., Li, S., Wu, W., et al. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102622 · Cited by 19 · see citing works

Influence of pegylation on peptide-mediated liposome fusion

Tomatsu, I., Marsden, H. R., Rabe, M., et al. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm11722j · Cited by 37 · see citing works

Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice

Ishida, T., Ichikawa, T., Ichihara, M., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.011 · Cited by 116 · see citing works